LXR 0151Alternative Names: Lexirin
Latest Information Update: 03 May 2000
At a glance
- Originator LXR Biotechnology
- Class Antidiarrhoeals
- Mechanism of Action Apoptosis inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Diarrhoea
Most Recent Events
- 03 May 2000 Discontinued-I for Diarrhoea in USA (PO)
- 12 Jun 1997 Suspended-I for Diarrhoea in USA (PO)
- 06 Aug 1996 New profile